| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |